QNCX
Quince Therapeutics, Inc.
29.20$
-4.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | 844.4% | – | – | 9.5% | – | – | – | – | – | – | – | |
| – | – | -844.4% | – | – | -9.5% | – | – | – | – | – | – | – | |
| – | – | 10,283.3% | – | – | 3,467.3% | – | – | – | – | – | – | – | |
| – | – | 13,808.3% | – | – | 2,550.0% | – | – | – | – | – | – | – | |
| – | – | 31,161.1% | – | – | 6,007.7% | – | – | – | – | – | – | – | |
| – | – | -31,161.1% | – | – | -6,017.3% | – | – | – | – | – | – | – | |
| – | – | 1,261.1% | – | – | 1,743.5% | – | – | – | – | – | – | – | |
| – | – | -30,883.3% | – | – | -7,411.3% | – | – | – | – | – | – | – | |
| – | – | 86.1% | – | – | 4.2% | – | – | – | – | – | – | – | |
| – | – | -30,969.4% | – | – | -7,415.5% | – | – | – | – | – | – | – | |
| – | – | -23,980.6% | – | – | -7,401.8% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.